A method for treatment of patients with chronic liver disease
CA 2116535 C · Owner: Novo Nordisk A/S · Inventors: Moeller, Soren; Skakkebaek, Niels E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Patients with chronic liver disease and consequently very low concentrations of ICF-1 in the blood, in spite of increased GH concentrations, are treated with periodically injections of hGH for a period both parameters being individually adjusted for the patients.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 18, 1992 and granted October 31, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 18, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 18, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.